We are live on ! Find out more
ST

Skorpios Trust Portfolio holdings

AUM $53.2M
1-Year Est. Return 90.96%
This Fund
S&P 500
This Quarter Est. Return
-5.65%
1 Year Est. Return
+90.96%
3 Year Est. Return
+173.58%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$452M
AUM Growth
–
Cap. Flow
+$455M
Cap. Flow %
100.73%
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–
Avg Time Held
0 quarters
Top 10 Avg Time Held
0 quarters
Top 20 Avg Time Held
0 quarters

Top Buys

Rank Stock Value
1
STOK icon
Stoke Therapeutics
STOK
+$345M
2
AKRO icon
Akero Therapeutics
AKRO
+$109M
3
ATVI
Activision Blizzard
ATVI
+$1.48M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$203K
5
OGN icon
Organon & Co
OGN
+$17.3K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 99.64%
2 Technology 0.32%
3 Miscellaneous 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
STOK icon
1
Stoke Therapeutics
STOK
$1.56B
$347M 76.67%
+14,443,681
New +$345M
2021 Q4
0 quarters
AKRO icon
2
DELISTED
Akero Therapeutics
AKRO
$104M 22.97%
+4,907,829
New +$109M
2021 Q4
0 quarters
ATVI
3
DELISTED
Activision Blizzard
ATVI
$1.44M 0.32%
+21,600
New +$1.48M
2021 Q4
0 quarters
XBI icon
4
State Street SPDR S&P Biotech ETF
XBI
$10B
$189K 0.04%
+1,686
New +$203K
2021 Q4
0 quarters
OGN icon
5
Organon & Co
OGN
$3.62B
$16K ﹤0.01%
+530
New +$17.3K
2021 Q4
0 quarters

Similar funds

ACM
Aurelius Capital Management New York $55.2M AUM 124.79% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
CCCPV
Castle Creek Capital Partners VI San Diego, California $55.9M AUM 7.91% 1-Year Est. Return
SGA
Siguler Guff Advisers New York $56.1M AUM 46.63% 1-Year Est. Return
NCFG
New Century Financial Group Princeton, New Jersey $56.3M AUM 16.99% 1-Year Est. Return
E
EnerVest Houston, Texas $50.1M AUM 2.25% 1-Year Est. Return
RPM
Ridgemont Partners Management Charlotte, North Carolina $49.7M AUM 26.51% 1-Year Est. Return
ECT
Ebor Charitable Trust Jackson, Wyoming $49.4M AUM 13.04% 1-Year Est. Return

Skorpios Trust's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for Skorpios Trust, which disclosed 5 positions worth $452M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Stoke Therapeutics: 14,443,681 shares worth $347M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, followed by Technology and Miscellaneous.

  • Skorpios Trust's largest Q4 2021 buy was Stoke Therapeutics: 14,443,681 shares worth $347M.
  • Skorpios Trust's ten largest holdings make up 100% of its $452M portfolio in Q4 2021.
  • Skorpios Trust disclosed 5 positions in Q4 2021, its first 13F filing on record.

Based on Skorpios Trust's 13F filing for Q4 2021, filed 27 Jan 2022.